PERSPECTIVE THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value
PERSPECTIVE THERAPEUTICS, INC. (CATX) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value of $0 as of 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue · last filed 2022-11-14
- 2022-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $0.00.
- 2022-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $0.00.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $0.00.
- 2021-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $289.00K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value |
|---|---|
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-13 |
| 2021-12-31 | $0.00 10-Q · filed 2022-02-09 |
| 2021-09-30 | $289.00K 10-Q · filed 2021-11-10 |
| 2021-03-31 | $1.61M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $12.00K 10-Q · filed 2021-02-09 |
| 2020-09-30 | $164.00K 10-Q · filed 2020-11-13 |
| 2020-03-31 | $63.00K 10-Q · filed 2020-05-13 |
| 2019-12-31 | $172.00K 10-Q · filed 2020-02-12 |
| 2019-03-31 | $10.00K 10-Q · filed 2019-05-10 |
| 2018-12-31 | $10.00K 10-Q · filed 2019-02-13 |
| 2018-09-30 | $78.00K 10-Q · filed 2018-11-09 |
| 2018-03-31 | $41.00K 10-Q · filed 2018-05-04 |
| 2017-12-31 | $36.00K 10-Q · filed 2018-02-09 |
| 2017-09-30 | $67.00K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $111.00K 10-K · filed 2017-09-28 |
| 2017-03-31 | $85.00K 10-Q · filed 2017-05-10 |
| 2016-12-31 | $82.00K 10-Q · filed 2017-02-09 |
| 2016-09-30 | $139.80K 10-Q · filed 2016-11-09 |
| 2016-06-30 | $250.37K 10-K · filed 2016-09-09 |
| 2016-03-31 | $274.20K 10-Q · filed 2016-05-10 |
| 2015-12-31 | $231.56K 10-Q · filed 2016-02-09 |
| 2015-09-30 | $583.08K 10-Q · filed 2015-11-09 |
| 2015-06-30 | $680.24K 10-K · filed 2015-09-14 |
| 2015-03-31 | $755.36K 10-Q · filed 2015-05-15 |
| 2014-12-31 | $644.93K 10-Q · filed 2015-02-17 |
| 2014-09-30 | $774.65K 10-Q · filed 2014-11-14 |
| 2014-06-30 | $2.52M 10-K · filed 2014-09-29 |
| 2014-03-31 | $1.71M 10-Q · filed 2014-05-15 |
| 2013-12-31 | $125.78K 10-Q · filed 2014-02-14 |
| 2013-09-30 | $219.58K 10-Q · filed 2013-11-14 |
| 2013-06-30 | $115.30K 10-K · filed 2013-09-30 |
| 2013-03-31 | $148.71K 10-Q · filed 2013-05-15 |
| 2012-12-31 | $280.47K 10-Q · filed 2013-02-14 |
| 2012-09-30 | $251.31K 10-Q · filed 2012-11-14 |
| 2012-06-30 | $460.95K 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |